BioLight Completed a Public Financing Round from Strategic and Public Investors

BioLight Life Sciences Investments Ltd., a unique Biomedical firm engaged in the management and commercialization of Biomed innovation, announced today that it has successfully raised over $28 million through shares issue at the market price to the company’s shareholders and other public investors. Among the investors are Mr. Israel Makov, Chairman of BioLight, Mr. Dilip Shanghvi, owner and CEO of Sun Pharmaceutical and Dexcel Pharma, a private company owned by Mr. Dan Oren.

Link to the complete article

Link to Newsroom

Comments are closed.